Table of Contents
Egyptian multimillionaire businesswoman Hend El-Sherbini has seen the market value of her stake in Integrated Diagnostics Holdings (IDH), a leading diagnostic service provider, decline by more than $24 million in the last six weeks.
According to data tracked by Billionaires.Africa, the market value of El-Sherbini’s stake in Integrated Diagnostics Holdings (IDH) has slumped by EGP756.39 million ($24.48 million) in the last 28 days — due to a sustained decline in the group’s share price on the Egyptian Stock Exchange.
IDH: Pioneering healthcare excellence across the Middle East and Africa
IDH is one of the Middle East and Africa’s leading consumer healthcare groups with more than 1,400 international-standard diagnostic tests; it operates through a branch network of 483 labs in four countries, making it Egypt’s largest diagnostic service provider.
El-Sherbini, a leading Egyptian businesswoman and business executive who was instrumental in the growth and transformation of the Egyptian consumer healthcare firm, owns a significant 26.71-percent stake in the company — this translates to 160,250,305 ordinary shares.
IDH share price drops 32.65 percent, impacting Hend El-Sherbini’s holdings
However, in the past 42 days, the share price of Integrated Diagnostics Holdings on the Egyptian Stock Exchange has declined by 32.65 percent, falling from a price of EGP 15.14 ($0.4901) on October 16 to EGP 10.196 ($0.3312) at the time of writing.
As a result of the double-digit percent slump in IDH shares, the market value of El-Sherbini’s stake in IDH has shrunk by EGP756.39 million ($24.48 million) in the last 42 days, falling from EGP2.32 billion ($74.96 million) on October 16 to EGP 1.56 billion ($50.49 million) at the time of writing.
Despite these setbacks, El-Sherbini remains one of Egypt’s richest businesswomen — she also ranks as one of the top investors on the Egyptian Stock Exchange.
The intelligence satisfies curiosity. The paid briefings satisfy strategy.
Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.
Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports
→ Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings
Subscribe now
